Send the following on WhatsApp
Continue to Chat德琪醫藥合作夥伴Karyopharm宣佈SIENDO全球III期臨床試驗達主要終點 https://geneonline.news/karyopharm-siendo-selinexor-drug/?variant=zh-cn
德琪醫藥合作夥伴Karyopharm宣佈SIENDO全球III期臨床試驗達主要終點 https://geneonline.news/karyopharm-siendo-selinexor-drug/?variant=zh-cn